Published in Clin Exp Immunol on September 01, 2002
Silica exposure and altered regulation of autoimmunity. Environ Health Prev Med (2014) 1.01
Detection, epitope-mapping and function of anti-Fas autoantibody in patients with silicosis. Immunology (2005) 0.83
Autoantibody against caspase-3, an executioner of apoptosis, in patients with systemic sclerosis. Rheumatol Int (2009) 0.81
Anti-ADAMTS13 IgG autoantibodies present in healthy individuals share linear epitopes with those in patients with thrombotic thrombocytopenic purpura. Haematologica (2014) 0.78
Environmental factors and human health: fibrous and particulate substance-induced immunological disorders and construction of a health-promoting living environment. Environ Health Prev Med (2015) 0.77
Keynote lecture in the 13th Japanese Society of Immunotoxicology (JSIT 2006) : -Pathophysiological Development and Immunotoxicology: what we have found from research related to silica and silicate such as asbestos-. Environ Health Prev Med (2007) 0.76
Expression of Fas antigen and Fas ligand in bronchoalveolar lavage from silicosis patients. Mediators Inflamm (2003) 0.76
Exacerbation of latent lupus: is the culprit acid-fast bacilli or antitubercular therapy? Clin Rheumatol (2013) 0.76
Evaluation of caspase 1 and sFas serum levels in patients with systemic sclerosis: correlation with lung dysfunction, joint and bone involvement. Mediators Inflamm (2003) 0.75
The contribution of the programmed cell death machinery in innate immune cells to lupus nephritis. Clin Immunol (2016) 0.75
Clinical evaluation of CENP-B and Scl-70 autoantibodies in silicosis patients. Exp Ther Med (2017) 0.75
FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death--inducing signaling complex. Cell (1996) 12.07
Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell (1995) 5.64
Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature (1992) 5.47
Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science (1995) 4.80
FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J (1997) 4.56
Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis. Proc Natl Acad Sci U S A (1997) 2.50
Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis. J Immunol (2000) 1.76
Repertoire dynamics of autoreactive T cells in multiple sclerosis patients and healthy subjects: epitope spreading versus clonal persistence. Brain (2000) 1.47
The three-dimensional structure of caspase-8: an initiator enzyme in apoptosis. Structure (1999) 1.39
Structure and chromosome localization of the human CASP8 gene. Gene (1999) 1.16
Elevated soluble Fas/APO-1 (CD95) levels in silicosis patients without clinical symptoms of autoimmune diseases or malignant tumours. Clin Exp Immunol (1997) 1.10
Caspase-8 specificity probed at subsite S(4): crystal structure of the caspase-8-Z-DEVD-cho complex. J Mol Biol (2000) 1.06
Shared early autoantibody recognition events in the development of anti-Sm B/B' in human lupus. Scand J Immunol (1999) 1.05
Does class switching contribute to remission in bullous pemphigoid? Acta Derm Venereol (1999) 1.03
IgG4 blocking effect on the release of antigen-specific histamine. J Investig Allergol Clin Immunol (1994) 1.01
Death domain receptors and their role in cell demise. J Interferon Cytokine Res (1998) 0.97
The use of seldi proteinchip arrays to monitor production of Alzheimer's betaamyloid in transfected cells. J Pept Sci (2000) 0.93
IgG autoantibodies from bullous pemphigoid (BP) patients bind antigenic sites on both the extracellular and the intracellular domains of the BP antigen 180. J Invest Dermatol (1999) 0.88
Pemphigus--paradigm of autoantibody-mediated autoimmunity. Skin Pharmacol Appl Skin Physiol (2001) 0.84
A non-thrombocytopenic bleeding disorder due to an IgG4-kappa anti-GPIIb/IIIa autoantibody. Br J Haematol (1996) 0.82
Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4. Science (1993) 4.39
Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature (1999) 3.93
Tissue pressure measurements as a determinant for the need of fasciotomy. Clin Orthop Relat Res (1976) 3.32
Calcium current-dependent and voltage-dependent inactivation of calcium channels in Helix aspersa. J Physiol (1981) 3.23
Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs. Nature (1990) 3.15
Classification criteria for polymyositis and dermatomyositis. J Rheumatol (1995) 3.08
Functional participation of the IL-2 receptor gamma chain in IL-7 receptor complexes. Science (1994) 2.78
The interleukin-2 receptor gamma chain: its role in the multiple cytokine receptor complexes and T cell development in XSCID. Annu Rev Immunol (1996) 2.50
Incidence of S-mephenytoin hydroxylation deficiency in a Korean population and the interphenotypic differences in diazepam pharmacokinetics. Clin Pharmacol Ther (1992) 2.18
Validation study of the in vitro micronucleus test in a Chinese hamster lung cell line (CHL/IU). Mutagenesis (1999) 2.16
Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system. J Virol (1998) 2.15
Hrs is associated with STAM, a signal-transducing adaptor molecule. Its suppressive effect on cytokine-induced cell growth. J Biol Chem (1997) 2.03
Activation of natural killer cells via the p75 interleukin 2 receptor. J Exp Med (1989) 1.95
Helper-cytotoxic T lymphocyte (CTL) determinant linkage required for priming of anti-HIV CD8+ CTL in vivo with peptide vaccine constructs. J Immunol (1994) 1.87
Visiting a forest, but not a city, increases human natural killer activity and expression of anti-cancer proteins. Int J Immunopathol Pharmacol (2008) 1.76
Interaction between calcium ions and surface charge as it relates to calcium currents. J Membr Biol (1983) 1.76
Association between Fc epsilon RI beta and atopic disorder in a Japanese population. Lancet (1996) 1.67
Severe growth defect in mouse cells lacking the telomerase RNA component. Nat Genet (1998) 1.64
Substructure of the thick filament of vertebrate striated muscle. J Mol Biol (1974) 1.61
A forest bathing trip increases human natural killer activity and expression of anti-cancer proteins in female subjects. J Biol Regul Homeost Agents (2008) 1.61
Isolation and composition of thick filaments from rabbit skeletal muscle. J Mol Biol (1973) 1.61
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Association between genetic variants of mast-cell chymase and eczema. Lancet (1996) 1.57
Differential expression of the IL-2 receptor subunits, p55 and p75 on various populations of primary peripheral blood mononuclear cells. J Immunol (1989) 1.55
Nucleotide specificity in DNA scission by neocarzinostatin. Proc Natl Acad Sci U S A (1978) 1.50
MicroRNA-21 induces resistance to the anti-tumour effect of interferon-α/5-fluorouracil in hepatocellular carcinoma cells. Br J Cancer (2010) 1.48
Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma. Br J Cancer (2013) 1.48
Serum angiotensin-1 converting enzyme activity processes a human immunodeficiency virus 1 gp160 peptide for presentation by major histocompatibility complex class I molecules. J Exp Med (1992) 1.46
Topical application of cyclosporine on guinea pig allergic contact dermatitis. Arch Dermatol (1988) 1.46
The significance of specific IgG4 antibodies to methyltetrahydrophthalic anhydride in occupationally exposed subjects. Clin Exp Allergy (1998) 1.44
Association of ALDH(2) genotypes and alcohol consumption with periodontitis. J Dent Res (2004) 1.43
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Genotypic and phenotypic diversity of rabies virus variants involved in human rabies: implications for postexposure prophylaxis. J Hum Virol (2000) 1.41
Possible involvement of a novel STAM-associated molecule "AMSH" in intracellular signal transduction mediated by cytokines. J Biol Chem (1999) 1.41
Should we discard the graft? Analysis of the renal grafts with a total ischemia time of more than 24 hours donated after cardiac death. Am J Transplant (2007) 1.40
Reconstitution of functional interleukin 2 receptor complexes on fibroblastoid cells: involvement of the cytoplasmic domain of the gamma chain in two distinct signaling pathways. Proc Natl Acad Sci U S A (1993) 1.39
Sharing of the IL-2 receptor gamma chain with the functional IL-9 receptor complex. Int Immunol (1995) 1.39
Effectiveness of preoperative administration of an N-methyl-D-aspartate antagonist to enhance cochlear neuron resistance to intraoperative traumatic stress: an experimental study. J Neurosurg (2000) 1.39
Cryptic dimer interface and domain organization of the extracellular region of metabotropic glutamate receptor subtype 1. J Biol Chem (2000) 1.39
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Grf40, A novel Grb2 family member, is involved in T cell signaling through interaction with SLP-76 and LAT. J Exp Med (1999) 1.39
The common gamma-chain for multiple cytokine receptors. Adv Immunol (1995) 1.38
Neurogenic bladder induced by brain abscess. Br J Urol (1995) 1.38
Hgs (Hrs), a FYVE domain protein, is involved in Smad signaling through cooperation with SARA. Mol Cell Biol (2000) 1.37
Evaluation of a simple loop-mediated isothermal amplification test kit for the diagnosis of tuberculosis. Int J Tuberc Lung Dis (2011) 1.37
Propagation of human parvovirus B19 in primary culture of erythroid lineage cells derived from fetal liver. J Virol (1989) 1.37
Healthy lifestyles are associated with higher natural killer cell activity. Prev Med (1992) 1.35
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
A simple method for tissue pressure determination. Arch Surg (1975) 1.34
Forest bathing enhances human natural killer activity and expression of anti-cancer proteins. Int J Immunopathol Pharmacol (2007) 1.34
Behavioral lifestyle and mental health status of Japanese factory workers. Prev Med (1994) 1.33
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Hyaline bodies in subepidermal papillae. Immunohistochemical studies in several dermatoses. Arch Dermatol (1969) 1.32
The relationship between pregnancy outcome and smooth endoplasmic reticulum clusters in MII human oocytes. Hum Reprod (2004) 1.29
Minimal requirements for peptide mediated activation of CD8+ CTL. Mol Immunol (1994) 1.28
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Evidence for structural changes in vertebrate thick filaments induced by calcium. J Mol Biol (1974) 1.26
Activation of peripheral blood T cells via the p75 interleukin 2 receptor. J Exp Med (1989) 1.25
Characterization of the three genotypes of low Km aldehyde dehydrogenase in a Japanese population. Hum Genet (1994) 1.24
Polyclonal human T-cell activation by silicate in vitro. Immunology (1994) 1.23
Volumetric determination of progression in autosomal dominant polycystic kidney disease by computed tomography. Kidney Int (2000) 1.22
Reconstitution of Ca2+-sensitive gelation of actin filaments with filamin, caldesmon and calmodulin. FEBS Lett (1982) 1.22
Excess beta 2 microglobulin promoting functional peptide association with purified soluble class I MHC molecules. Nature (1991) 1.22
Brain death and its influence on donor organ quality and outcome after transplantation. Transplantation (1999) 1.22
Interleukin 2 (IL-2)-induced tyrosine phosphorylation of IL-2 receptor p75. J Exp Med (1990) 1.20
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
The mouse prostaglandin E receptor EP2 subtype: cloning, expression, and northern blot analysis. FEBS Lett (1995) 1.16
Activation-induced cell death in human peripheral blood lymphocytes after stimulation with silicate in vitro. Int J Oncol (1998) 1.16
Left renal vein hypertension in patients with left renal bleeding of unknown origin. Radiology (1986) 1.16
Association of EXT1 and EXT2, hereditary multiple exostoses gene products, in Golgi apparatus. Biochem Biophys Res Commun (2000) 1.15
Nucleotide sequence of a region in 23-S RNA adjacent to peptidyl transferase catalytic center of Escherichia coli ribosomes. Eur J Biochem (1977) 1.15
Occupational asthma from cobalt sensitivity in workers exposed to hard metal dust. Chest (1989) 1.15
The central nervous system inflammatory response to neurotropic virus infection is peroxynitrite dependent. J Immunol (2001) 1.14
Partial purification and properties of urokinase inhibitor from human placenta. J Biochem (1970) 1.14
The effect of prolonged euglycemic hyperinsulinemia on lean body mass after severe burn. Surgery (2002) 1.14
Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13
Serum antibodies to carbonic anhydrase IV in patients with autoimmune pancreatitis. Gut (2005) 1.13
Soluble Fas mRNA is dominantly expressed in cases with silicosis. Immunology (1998) 1.12
The importance of dominant negative effects of amino acid side chain substitution in peptide-MHC molecule interactions and T cell recognition. J Immunol (1993) 1.12
Caldesmon, a calmodulin-binding, F actin-interacting protein, is present in aorta, uterus and platelets. FEBS Lett (1983) 1.11
Elevated soluble Fas/APO-1 (CD95) levels in silicosis patients without clinical symptoms of autoimmune diseases or malignant tumours. Clin Exp Immunol (1997) 1.10
Overexpression of cytochrome C by a recombinant rabies virus attenuates pathogenicity and enhances antiviral immunity. J Virol (2001) 1.09
Metastases to the penis from carcinoma of the prostate. Int J Urol (2001) 1.09
Isolation and physical chemical properties of an M-line protein from skeletal muscle. J Biol Chem (1972) 1.09
Stimulation of prostaglandin E2 synthesis in cloned osteoblastic cells of mouse (MC3T3-E1) by epidermal growth factor. J Biol Chem (1986) 1.09
Exercise and aspirin increase levels of circulating gliadin peptides in patients with wheat-dependent exercise-induced anaphylaxis. Clin Exp Allergy (2005) 1.09
Urokinase inhibitor in human placenta. Nature (1968) 1.08
STAM2, a new member of the STAM family, binding to the Janus kinases. FEBS Lett (2000) 1.08
A review of the genotoxicity of 1-ethyl-1-nitrosourea. Mutat Res (1993) 1.08
IL-2 receptor subunit, p75: direct demonstration of its IL-2 binding ability by using a novel monoclonal antibody. Int Immunol (1989) 1.08
Intraoperative recordings of evoked extraocular muscle activities to monitor ocular motor nerve function. Neurosurgery (1993) 1.08
Search for tb resonances in proton-proton collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.07
Biotransformation of digitoxigenin by cultured Strophanthus hybrid cells. Phytochemistry (1998) 1.07